Literature DB >> 18420927

The global circulation of seasonal influenza A (H3N2) viruses.

Colin A Russell1, Terry C Jones, Ian G Barr, Nancy J Cox, Rebecca J Garten, Vicky Gregory, Ian D Gust, Alan W Hampson, Alan J Hay, Aeron C Hurt, Jan C de Jong, Anne Kelso, Alexander I Klimov, Tsutomu Kageyama, Naomi Komadina, Alan S Lapedes, Yi P Lin, Ana Mosterin, Masatsugu Obuchi, Takato Odagiri, Albert D M E Osterhaus, Guus F Rimmelzwaan, Michael W Shaw, Eugene Skepner, Klaus Stohr, Masato Tashiro, Ron A M Fouchier, Derek J Smith.   

Abstract

Antigenic and genetic analysis of the hemagglutinin of approximately 13,000 human influenza A (H3N2) viruses from six continents during 2002-2007 revealed that there was continuous circulation in east and Southeast Asia (E-SE Asia) via a region-wide network of temporally overlapping epidemics and that epidemics in the temperate regions were seeded from this network each year. Seed strains generally first reached Oceania, North America, and Europe, and later South America. This evidence suggests that once A (H3N2) viruses leave E-SE Asia, they are unlikely to contribute to long-term viral evolution. If the trends observed during this period are an accurate representation of overall patterns of spread, then the antigenic characteristics of A (H3N2) viruses outside E-SE Asia may be forecast each year based on surveillance within E-SE Asia, with consequent improvements to vaccine strain selection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420927     DOI: 10.1126/science.1154137

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  337 in total

1.  Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007.

Authors:  N S Lewis; J M Daly; C A Russell; D L Horton; E Skepner; N A Bryant; D F Burke; A S Rash; J L N Wood; T M Chambers; R A M Fouchier; J A Mumford; D M Elton; D J Smith
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Does history repeat itself? Wavelets and the phylodynamics of influenza A.

Authors:  Jennifer A Tom; Janet S Sinsheimer; Marc A Suchard
Journal:  Mol Biol Evol       Date:  2011-12-08       Impact factor: 16.240

3.  Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.

Authors:  Nimalan Arinaminpathy; Oliver Ratmann; Katia Koelle; Suzanne L Epstein; Graeme E Price; Cecile Viboud; Mark A Miller; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

4.  Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation.

Authors:  Xiangjun Du; Libo Dong; Yu Lan; Yousong Peng; Aiping Wu; Ye Zhang; Weijuan Huang; Dayan Wang; Min Wang; Yuanji Guo; Yuelong Shu; Taijiao Jiang
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

5.  Experimental evidence that source genetic variation drives pathogen emergence.

Authors:  John J Dennehy; Nicholas A Friedenberg; Robert C McBride; Robert D Holt; Paul E Turner
Journal:  Proc Biol Sci       Date:  2010-05-19       Impact factor: 5.349

Review 6.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

7.  The effects of a deleterious mutation load on patterns of influenza A/H3N2's antigenic evolution in humans.

Authors:  Katia Koelle; David A Rasmussen
Journal:  Elife       Date:  2015-09-15       Impact factor: 8.140

8.  Complexities of Estimating Evolutionary Rates in Viruses.

Authors:  Edward C Holmes
Journal:  J Virol       Date:  2016-01-28       Impact factor: 5.103

Review 9.  Contrasting the epidemiological and evolutionary dynamics of influenza spatial transmission.

Authors:  Cécile Viboud; Martha I Nelson; Yi Tan; Edward C Holmes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

Review 10.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.